Perone Thomas Michael has filed 3 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 28125 shares of Ovid Therapeutics Inc. ($OVID) on February 22, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 22, 2024 | Ovid Therapeutics Inc. | $OVID | Perone Thomas Michael | General Counsel, Secretary | A | Common Stock | 28125 | $0.00 | 28,125.0000 | 0 | 9999.99% | 0.00% |
| Feb. 22, 2024 | Ovid Therapeutics Inc. | $OVID | Perone Thomas Michael | General Counsel, Secretary | A | Stock Option (Right to Buy) | 168750 | $0.00 | 168,750.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Ovid Therapeutics Inc. | $OVID | Perone Thomas Michael | General Counsel, Secretary | A | Stock Option (Right to Buy) | 175000 | $0.00 | 175,000.0000 | 0 | 9999.99% | 0.00% |